[Current developments and perspectives in targeted therapies]. / Aktuelle Entwicklungen und Perspektiven zielgerichteter Therapien.
Onkologie
; 33 Suppl 5: 2-11, 2010.
Article
em De
| MEDLINE
| ID: mdl-20523101
ABSTRACT
Many different approaches for improving the prognosis of patients with advanced non-small-cell lung cancer (NSCLC) are currently being investigated. This article discusses the significance of maintenance therapy after primary chemotherapy and reviews study data on second-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), inhibitors of insulin-like growth factor receptors (IGFR), vascular-disrupting agents (VDAs) and multi-TKIs of vascular endothelial growth factor receptors (VEGFR). The article also looks at the future prospects of using genetic markers in the field of NSCLC.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Drogas em Investigação
/
Sistemas de Liberação de Medicamentos
/
Carcinoma Pulmonar de Células não Pequenas
/
Receptores ErbB
/
Neoplasias Pulmonares
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
De
Revista:
Onkologie
Ano de publicação:
2010
Tipo de documento:
Article